On-line Hemodiafiltration Did Not Induce an Overproduction of Oxidative Stress and Inflammatory Cytokines in Intensive Care Unit-acute Kidney Injury
Overview
Authors
Affiliations
Background: Though on-line intermittent hemodiafiltration (OL-IHDF) is a routine therapy for chronic dialysis patients, it is not yet widespread used in critically ill patients. This study was undergone to evaluate efficiency and tolerance of OL-IHDF and to appreciate inflammatory consequences of its use in intensive care unit (ICU)-acute kidney injury (AKI) patients.
Methods: In this prospective cohort study conducted in a medical academic ICU in France, 30 AKI patients who underwent OL-IHDF were included. OL-HDF used an ultrapure water production: AQ 1250 line with double reverse osmosis, a generator 5008 with a 1.8m dialyzer with Polysulfone membrane (Fresenius Medical Care). Tolerance and efficiency of OL-IHDF were evaluated as well as its inflammatory risk by the measurement of plasma concentrations of proinflammatory (Interleukin 6, IL1β, IL8, Interferon γ) and anti-inflammatory (IL4, IL10) cytokines, Epidermal growth factor (EGF), Vascular Endothelial growth factor (VEGF) and Macrophage Chemoattractive Protein-1 (MCP-1) before and after sessions.
Results: Intradialytic hypotensive events were observed during 27/203 OL-IHDF sessions accounting for a mal-tolerated session's rate at 13.3%. Mean delivered urea Kt/V per session was 1.12 ± 0.27 with a percentage of reduction for urea, creatinine, β2-microglobulin and cystatine C at 61.6 ± 8.8%, 55.3 ± 6.7%, 51.5 ± 8.7% and 44.5 ± 9.8% respectively. Production of superoxide anion by leukocytes, mean levels of pro- and anti-inflammatory cytokines and plasmatic concentrations of EGF, VEGF and MCP-1 did not differ before and after OL-IHDF sessions. We observed however a significant decrease of mean TNFα plasmatic concentrations from 8.2 ± 5.8 to 4.8 ± 3.5 pg/ml at the end of OL-IHDF.
Conclusions: OL-IHDF was not associated with an increase in pro and anti-inflammatory cytokines, oxidative stress or EGF, VEGF and MCP-1 in AKI patients and seems therefore a secure and feasible modality in ICUs.
Rootjes P, Grooteman M, Budding A, Bontkes H, Wijngaarden G, Nube M Kidney Int Rep. 2025; 10(1):109-119.
PMID: 39810793 PMC: 11725968. DOI: 10.1016/j.ekir.2024.09.025.
Hemofiltration in Patients with Severe Acute Pancreatitis (Review).
Boyarinov G, Zubeyev P, Mokrov K, Voyennov O Sovrem Tekhnologii Med. 2021; 12(1):105-121.
PMID: 34513045 PMC: 8353697. DOI: 10.17691/stm2020.12.1.14.
Liu J, Jia Z, Gong W Front Immunol. 2021; 12:680648.
PMID: 34248963 PMC: 8264283. DOI: 10.3389/fimmu.2021.680648.
Li Y, Jiang X, Song L, Yang M, Pan J Biosci Rep. 2020; 40(4).
PMID: 32285909 PMC: 7189607. DOI: 10.1042/BSR20192920.
Navarro-Garcia J, Rodriguez-Sanchez E, Aceves-Ripoll J, Abarca-Zabalia J, Susmozas-Sanchez A, Gonzalez Lafuente L Nutrients. 2019; 11(11).
PMID: 31744232 PMC: 6893513. DOI: 10.3390/nu11112809.